These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3100915)

  • 1. Characterization of purified Shiga toxin from Shigella dysenteriae 1.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1986; 30(11):1115-27. PubMed ID: 3100915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and some properties of Shiga-like toxin from Escherichia coli O157:H7 that is immunologically identical to Shiga toxin.
    Noda M; Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 May; 2(5):339-49. PubMed ID: 3148810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin.
    Yutsudo T; Nakabayashi N; Hirayama T; Takeda Y
    Microb Pathog; 1987 Jul; 3(1):21-30. PubMed ID: 3143036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a lethal toxin produced by Shigella dysenteriae.
    Okamoto K; Takeda Y; Miwatani T
    Toxicon; 1982; 20(2):451-6. PubMed ID: 7043787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and biological characterization of shiga toxin from Shigella dysenteriae 1.
    Brown JE; Griffin DE; Rothman SW; Doctor BP
    Infect Immun; 1982 Jun; 36(3):996-1005. PubMed ID: 7047403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical characterization of A and B subunits of Shiga toxin and reconstitution of holotoxin from isolated subunits.
    Yutsudo T; Honda T; Miwatani T; Takeda Y
    Microbiol Immunol; 1987; 31(3):189-97. PubMed ID: 3302622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and some properties of a Vero toxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2).
    Oku Y; Yutsudo T; Hirayama T; O'Brien AD; Takeda Y
    Microb Pathog; 1989 Feb; 6(2):113-22. PubMed ID: 2654533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.
    O'Brien AD; LaVeck GD
    Infect Immun; 1983 May; 40(2):675-83. PubMed ID: 6341244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography.
    O'Brien AD; LaVeck GD; Griffin DE; Thompson MR
    Infect Immun; 1980 Oct; 30(1):170-9. PubMed ID: 7002787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.
    Donohue-Rolfe A; Keusch GT; Edson C; Thorley-Lawson D; Jacewicz M
    J Exp Med; 1984 Dec; 160(6):1767-81. PubMed ID: 6392471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal toxicity of Shigella dysenteriae cytotoxin: evidence that the neurotoxic, enterotoxic, and cytotoxic activities are due to one toxin.
    Eiklid K; Olsnes S
    J Immunol; 1983 Jan; 130(1):380-4. PubMed ID: 6336624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on shiga-like toxin produced by enterohemorrhagic Escherichia coli: purification and characterization of the toxin and development of methods for identifying the toxin.
    Kongmuang U
    Med J Osaka Univ; 1989 Mar; 38(1-4):39-49. PubMed ID: 2485395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile.
    Banno Y; Kobayashi T; Kono H; Watanabe K; Ueno K; Nozawa Y
    Rev Infect Dis; 1984; 6 Suppl 1():S11-20. PubMed ID: 6426016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of monoclonal antibodies to Shiga toxin.
    Griffin DE; Gentry MK; Brown JE
    Infect Immun; 1983 Jul; 41(1):430-3. PubMed ID: 6345399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of an Escherichia coli Shiga-like toxin II variant.
    MacLeod DL; Gyles CL
    Infect Immun; 1990 May; 58(5):1232-9. PubMed ID: 2182539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B.
    Griffin DE; Gemski P
    Infect Immun; 1983 Apr; 40(1):425-8. PubMed ID: 6299964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical and cytotoxic activities of Shigella dysenteriae 1 (shiga) and shiga-like toxins.
    O'Brien AD; Laveck GD
    Infect Immun; 1982 Mar; 35(3):1151-4. PubMed ID: 7040247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production, characterization and immunodiagnostic application of a monoclonal antibody to Shiga toxin.
    Qadri F; Mohi MG; Azim T; Faruque SM; Kabir AK; Albert MJ
    J Diarrhoeal Dis Res; 1996 Jun; 14(2):95-100. PubMed ID: 8870402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and crystallization of Shiga toxin from Shigella dysenteriae.
    Kozlov YV; Chernaia MM; Fraser ME; James MN
    J Mol Biol; 1993 Jul; 232(2):704-6. PubMed ID: 8345529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin.
    Kongmuang U; Honda T; Miwatani T
    Infect Immun; 1988 Sep; 56(9):2491-4. PubMed ID: 3045003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.